Vancouver, BC / ACCESSWIRE / July 8, 2014 / Auxellence Health Corporation (formerly 0924888 BC Ltd.) (the "Company"), announces that it has completed the three-cornered amalgamation (the "Amalgamation") pursuant to the amalgamation agreement ("Amalgamation Agreement") dated May 21, 2013 among the Company, C&C Cosmeceuticals Corporation ("C&C"), and 0961896 BC Ltd. ("Newco"), a wholly-owned subsidiary of the Company incorporated solely for the purpose of completing the Amalgamation (as defined herein), pursuant to which C&C amalgamated with Newco to form a combined entity ("Amalco") and the Company
issued 39,825,000 common shares in the capital of the Company to the holders of common
shares in the capital of C&C on the basis of one and one quarter (1.25) shares of the Company for one share of C&C held by the C&C shareholder. Upon completion of the Amalgamation (the "Amalgamation"), Amalco became a wholly-owned subsidiary of the Company.
Following the closing of the Amalgamation, the Company has adopted the business of C&C, which is that of a health technology company providing high-level online personal health solutions for consumers with problems related to weight management, and acneic skin conditions. Also, in connection with the Amalgamation, 0924888 B.C. Ltd. had changed its name to "Auxellence Health Corporation" to better reflect the business of the Company.
The Company will maintain HLB Cinnamon Jang Willoughby, Chartered Accountants as its auditors and will maintain Computershare Trust Company of Canada as its transfer agent and registrar. The Company's shares have been approved for listing on the Canadian National Stock Exchange (CNSX) under the symbol "AID".
Auxellence Health Corporation
Name: Sydney Au
Position: Chief Executive Officer
Contact: [email protected]
Telephone: (604) 780-3311
Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither CNSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CNSX) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Auxellence Health Corporation